Big Pharma bids to build bridges in Ireland
Irish industry’s chief looks for partnership as he admits trust is lacking
Irish industry’s chief looks for partnership as he admits trust is lacking
Ex-chief of innovative health unit Bourla to assume control as Read becomes executive chairman
Sales slip for third quarter in a row as leading drug group misses analyst projections
Pharma giant facing into expiry of key patents and investors are becoming itchy
Pharma giant increase US price of nearly 100 medicines by average of 20 per cent this year
Company’s shares down 1.3% in premarket trading after it says it will not separate
Several hundred jobs likely to be created at former Wyeth facility in west Dublin
Impact on share prices of uncertainty over UK’s EU future difficult to calculate
Ian Read says rules to stop inversions will create ‘permanent advantage’ for rivals
Except for the firms involved, few in the US or Ireland benefit from inversion deals
Activist investor Carl Icahn argues that deal will open the floodgates for other companies to leave the US
Democrats call for US tax reform after Pfizer, Allergan agree $160bn Irish-based merger
Deal makes Ireland home to the largest pharmaceutical company in the world
Pfizer $160bn purchase of Allergan will see firm move HQ to Dublin
Offer, the biggest ever in the healthcare sector, values Allergan shares at $363.63 each
Merger will create world’s largest drugmaker and renew focus on Ireland’s role in tax inversion
Cantillon: Pfizer/Allergan deal the biggest of any sort yet attempted in pharma/medtech sector
CEO warns that any attempt to block a takeover by Pfizer would be a “short-sighted intervention”
No one questioning wisdom of approach or ability of companies to do a deal
Takeover could offer tax advantages given that Allergan is based in Dublin
Sales fell 2 per cent, hurt by generic competition and expiration of a deal with Amgen
Acquisition could allow the US drugmaker to move overseas and reduce taxes
British firm says US company had failed to make a compelling case
Plans to create world’s largest drug company in doubt as Pfizer offer fails to meet approval
This week: Straight-talk coins, ‘monetary morphine’ and stock ticker symbols with a difference
MPs told new entity would deliver much better outcomes for range of diseases
Westminster not happy with Ian Reid’s pledges on takeover of AstraZeneca
Chief executive Ian Read faces hostile questions over his proposed $106 billion play for UK firm
US firm says commitments to Britain are legally binding
Group is not known for being backwards when it comes to rationalisation
Pharma company’s record of cutting jobs after mergers has provoked a political backlash
US pharma giant reports first quarter sales of $730 million, below analyst estimates
US pharma giant is currently in a $100 million battle for Britain’s AstraZeneca
Chief executive Ian Read arrives in London for talks with government ministers
Crosswords & puzzles to keep you challenged and entertained
How does a post-Brexit world shape the identity and relationship of these islands
Inquests into the nightclub fire that led to the deaths of 48 people
Weddings, Births, Deaths and other family notices